Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease
Clinical trial NCT04026165 · COMPLETED
Trial details
- NCT number
- NCT04026165
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-24
- Primary completion
- 2021-09-03
- Enrollment
- 384
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.